Current Price
Celgene Corporation (CELG-R) is a prominent biopharmaceutical firm specializing in innovative therapies for cancer and inflammatory disorders. Renowned for its robust research and development efforts, Celgene has signifi...|
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AAbony Acqu... | AACOU | — | — | — | — | — | — | — |
| 2. | AApogee Acq... | AACPU | — | — | — | — | — | — | — |
| 3. | AAres Acqui... | AACTWS | — | — | — | — | — | — | — |
| 4. | AAres Acqui... | AAC-U | — | — | — | — | — | — | — |
| 5. | AAres Acqui... | AAC-WS | — | — | — | — | — | — | — |
Consolidated Figures in Millions / View Standalone.
| Quarter (M) |
|---|
Revenue |
COGS |
Gross Profit |
Gross Profit % |
EBIT |
OPM % |
Non-Operating Income |
PBT |
Income Tax |
Tax Rate % |
Net Income |
NPM % |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Revenue |
COGS |
Gross Profit |
Gross Profit % |
EBIT |
OPM % |
Non-Operating Income |
PBT |
Income Tax |
Tax Rate % |
Net Income |
NPM % |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Total Assets |
Total Liabilities |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Net CFNet Cash Flow |
FCFFree Cash Flow |
Financial ratios and valuation metrics by fiscal year.
| Period |
|---|
Cash Conversion |
Payout Ratio |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns BristolMyers Squibb Company. Contingent Value Rt 12312030, from SEC filings
No SEC ownership filings for this company yet.
BristolMyers Squibb Company. Contingent Value Rt 12312030's SEC filings and earnings call transcripts
No SEC filings for this company yet.
What recent news says about BristolMyers Squibb Company. Contingent Value Rt 12312030, scored for sentiment.